中性脊髓酶2:对于中枢神经系统疾病来说是一个有前途的药物标
Meixiang Huang1, Matthew Stremlau1, Jason Zavras2
1Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, United States; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, United States.
Advances in pharmacology (San Diego, Calif.)
|February 10, 2025
概括
中性脊髓酶2 (nSMase2) 对于胺的产生和大脑健康至关重要. 它的失调与神经疾病有关,突出了潜在的治疗点.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
背景情况:
- 中性脊髓酶2 (nSMase2) 是脊髓脂代谢中的一个关键酶,产生胺,一种脂质介质.
- nSMase2在中枢神经系统 (CNS) 中高度表达,并在神经元功能中发挥作用.
- 对nSMase2的失调与各种神经系统疾病有关,包括阿尔茨海默氏症和帕金森病.
研究的目的:
- 审查nSMase2在中枢神经系统中的关键作用.
- 探索其在神经和非神经疾病中的参与.
- 讨论针对nSMase2的治疗策略2.
主要方法:
- 关于nSMase2功能,调节和疾病影响的文献综述.
- 对nSMase2在脂代谢和EV生物发生中的作用的分析.
- 对nSMase2抑制剂的治疗潜力的研究.
主要成果:
- nSMase2是陶胺产生的组成部分,影响着亡,炎症和膜动态.
- nSMase2失调与神经退行性疾病 (AD,PD,ALS) 和神经病毒感染有关.
- 对nSMase2的药理抑制显示出对相关病理的治疗前景.
结论:
- nSMase2是中枢神经系统健康和疾病发病的一个重要因素.
- 准nSMase2为复杂疾病提供了潜在的治疗途径.
- 需要进一步的研究来完善nSMase2抑制剂的临床用途.
相关概念视频
Ligand-gated Ion Channels
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Therapeutic Uses
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...


